Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Literature
1.
Hata M, Tsujikawa A, Miyake M, Yamashiro K, Ooto S, Oishi A, Nakata I, Takahashi A, Yoshimura N (2015) Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab. Graefes Arch Clin Exp Ophthalmol 253:189–197CrossRefPubMed
2.
Tan CS, Ngo WK, Lim LW, Lim TH (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98:1528–1533CrossRefPubMed
3.
Tamura H, Tsujikawa A, Otani A, Gotoh N, Sasahara M, Kameda T, Iwama D, Yodoi Y, Mandai M, Yoshimura N (2007) Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography. Br J Ophthalmol 91:1152–1159CrossRefPubMedPubMedCentral
4.
Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453–1464CrossRefPubMed
5.
Hirami Y, Tsujikawa A, Otani A, Yodoi Y, Aikawa H, Mandai M, Yoshimura N (2007) Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 27:335–341CrossRefPubMed
Metadata
Title
Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy
Authors
Masayuki Hata
Akitaka Tsujikawa
Nagahisa Yoshimura
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 5/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-3163-3

Other articles of this Issue 5/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2016 Go to the issue

Neurophthalmology

Impaired systemic vascular endothelial function in patients with non-arteritic anterior ischaemic optic neuropathy

Retinal Disorders

Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up)

Basic Science

Development and testing of an automated computer tablet-based method for self-testing of high and low contrast near visual acuity in ophthalmic patients

Miscellaneous

The influence of varying the number of characters per row on the accuracy and reproducibility of the ETDRS visual acuity chart

Retinal Disorders

Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy

Pediatrics

Intraocular cytokines imbalance in congenital cataract and its impact on posterior capsule opacification